KHD Medical

This service is rated as Good overall.

The key questions are rated as:

Are services safe? – Good

Are services effective? – Good

Are services caring? – Good

Are services responsive? – Good

Are services well-led? – Requires improvement

We carried out an announced comprehensive inspection at KHD Medical on 11 July 2023 as part of our inspection programme and to provide a rating for the service.

KHD Medical provides an independent GP Consulting service to children and adults of all ages, slimming services to those over 18 years and some aesthetic procedures that fall within the scope of registration for example, the treatment of hyperhidrosis and IV Vitamins.

This service is registered with CQC under the Health and Social Care Act 2008 in respect of some, but not all, of the services it provides. There are some exemptions from regulation by CQC which relate to particular types of regulated activities and services and these are set out in Schedule 1 and Schedule 2 of The Health and Social Care Act 2008 (Regulated Activities) Regulations 2014. KHD Medical provides a range of non-surgical cosmetic interventions, for example, various skin treatments which are not within CQC scope of registration. Therefore, we did not inspect or report on these services.

Dr Dhanji is the registered manager for the service. A registered manager is a person who is registered with the Care Quality Commission to manage the service. Like registered providers, they are ‘registered persons’. Registered persons have legal responsibility for meeting the requirements in the Health and Social Care Act 2008 and associated Regulations about how the service is run.

Our key findings were:

• The service provided care in a way that kept patients safe.
• Clinical records seen demonstrated the delivery of safe and effective care and treatment with appropriate follow up provided.
• The provider worked with other services when needed to ensure patient safety.
• We found appropriate management of medicines and prescribing.
• We found the premises were well maintained and there were systems and processes to minimise the risk of infection.
• There were policies and procures in place to support the running of the services and risk assessments had been completed where appropriate. However, we identified some areas where systems and processes needed strengthening, for example assurance of parental responsibility of children seen, maintenance of clinical equipment, management of records should the provider cease trading and risk assessments for the provision of emergency medicines against services provided.
• The provider had systems for acting on and learning from incidents and complaints. However, information to support patients in raising a concern was not clearly available.
• Training records showed the provider had received relevant training for the services they provided.
• There was limited evidence of quality improvement initiatives such as clinical audits, which we were advised was due to the lack of data at present to do this.
• Arrangements were in place to support patients to make informed decisions about the care and treatment they received. However, the consent form did not include all relevant information.
• Patient feedback seen showed that patients were treated with kindness and respect.
• Patients were able to receive timely care and treatment to meet their needs and reasonable adjustments were made to help patients access care.
• We found the service was largely well led but needed to strengthen some of the governance arrangements to support the provision of a high-quality service.

The areas where the provider must make improvements as they are in breach of regulations are:

• Establish effective systems and processes to ensure good governance in accordance with the fundamental standards of care.

The areas where the provider should make improvements are:

• Formalise systems for assuring the parental authority of children seen at the service.
• Undertake quality improvement initiatives to support the delivery of high-quality care.
• Incorporate the use of off-label medicines within the consent process.

Dr Sean O’Kelly BSc MB ChB MSc DCH FRCA

Chief Inspector of Health Care